One way to picture the progression is by comparing generations of treatment
Meeting highlights PRAC 2326 October 2023 GLP-1 receptor agonists: available evidence not supporting link with thyroid cancer
Available from: National Center for Biotechnology Information (NCBI): Jastreboff AM, Kaplan LM, Fras JP, Wu Q, Du Y, Gurbuz S, et al
Diabetes Care (2017) 40(11):155664
A new plan to lower the price of GLP-1s The Trump administration announced in early November that it had struck a deal with leading GLP-1 pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, to lower consumer prices for GLP-1 medications
Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial